10-Q: Jackson Acquisition Company II Reports Net Income of $2.2 Million for Q1 2025

Sentiment:

Quarterly Report


Jackson Acquisition Company II, a blank check company, reported a net income of $2.2 million for the quarter ended March 31, 2025, primarily driven by interest earned on marketable securities held in trust.

Summary

  • Jackson Acquisition Company II is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination.
  • The company reported a net income of $2,227,401 for the three months ended March 31, 2025.
  • This net income was primarily driven by $2,433,722 in interest earned on marketable securities held in the Trust Account, offset by $206,321 in operational costs.
  • As of March 31, 2025, the company had $755,968 in cash and $235,292,200 in investments held in the Trust Account.
  • The company completed its Initial Public Offering (IPO) on December 11, 2024, raising gross proceeds of $230,000,000 through the sale of 23,000,000 units at $10.00 per unit.
  • Simultaneously with the IPO, the company sold 840,000 private placement units at $10.00 per unit, generating gross proceeds of $8,400,000.
  • The company has until December 11, 2026, to complete a business combination.
  • If a business combination is not completed within this timeframe, the company will liquidate and distribute the funds held in the Trust Account to its public shareholders.

Sentiment

Score: 7

Explanation: The document presents a neutral to slightly positive outlook. The company is performing as expected for a SPAC in its early stages, with significant funds available for a business combination. However, the lack of a identified target and the limited time to complete a deal introduce some uncertainty.

Positives

  • The company generated significant net income due to interest earned on the Trust Account.
  • The company has a substantial amount of funds available in its Trust Account to pursue a business combination.
  • The company has sufficient funds for working capital needs for at least one year from the date of issuance of the financial statements.

Negatives

  • The company has not yet identified a target for a business combination.
  • The company is incurring operational costs while searching for a target business.
  • If the company is unable to complete a Business Combination within the Combination Period, the company will liquidate.

Risks

  • The company's ability to complete a business combination is subject to various risks and uncertainties.
  • Geopolitical instability, such as the Russia-Ukraine conflict and the Israel-Hamas conflict, could adversely affect the company's search for a business combination.
  • The company may need to obtain additional financing to complete a business combination or to finance the operations of the target business.
  • The proceeds deposited in the Trust Account could become subject to the claims of the Company's creditors, if any, which could have priority over the claims of the Company's public shareholders.

Future Outlook

The company intends to complete a business combination by December 11, 2026, and expects to continue to incur significant costs in pursuit of its acquisition plans.

Industry Context

SPACs have become a popular alternative to traditional IPOs, particularly in sectors like healthcare. The company's focus on healthcare services and technology aligns with current industry trends.

Comparison to Industry Standards

  • SPACs typically aim to complete a business combination within 18-24 months of their IPO.
  • The size of the Trust Account is comparable to other SPACs targeting similar sectors.
  • The underwriting fees and other offering costs are within the typical range for SPAC IPOs.
  • Comparable companies include other healthcare-focused SPACs such as DHC Acquisition Corp. and CM Life Science Opportunities II.

Related Party Transactions

  • The company entered into an agreement with the Sponsor to pay $10,000 per month for office space and administrative services.
  • The company issued an unsecured promissory note to the Sponsor, which was amended on May 7, 2025, to be payable upon consummation of a business combination or liquidation.

Stakeholder Impact

  • Shareholders will benefit from a successful business combination.
  • Employees of the target business will be impacted by the business combination.
  • The company's creditors could potentially have claims on the Trust Account.

Next Steps

  • The company will continue to seek a suitable target for a business combination.
  • The company will perform due diligence on prospective target businesses.
  • The company will negotiate and complete a business combination.

Key Dates

DateDescription
2024-09-11Company incorporated as a Cayman Islands exempted company
2024-09-13Sponsor paid $25,000 for Founder Shares
2024-11-18Sponsor transferred 200,000 Founder Shares to officers and directors
2024-12-09Registration statement for IPO declared effective
2024-12-11Company consummated Initial Public Offering (IPO) and sale of Private Placement Units
2025-03-31End of the reporting period for the 10-Q
2025-05-07Promissory Note was amended
2025-05-08Date of report
2026-12-11Deadline to complete a business combination

Keywords

business combination, SPAC, acquisition, IPO, trust account, healthcare, blank check company

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.